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This article unfortunately contained errors in two places.
1. The two columns of data in Table 1 were under the
wrong headings. The correct version of Table 1 is given
here:
2. Incorrect percentages were given in the last paragraph
of the ‘‘Results’’ section, immediately before the ‘‘Dis-
cussion’’. The corrected paragraph is as follows:
In 2005 in the prescription (Rx) group of N2B analge-
sics, combination products accounted for approx. 33% of
all Rx analgesics in terms of SU. The most important
combinations are tilidine plus naloxone (14% of all SU in
the Rx group), followed by codeine plus paracetamol
(12%). The predominating single products in the Rx group
are metamizole (36%) and tramadol (21%). Growth in the
Rx group can be seen for both the combinations named and
the single products.
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Table 1 Relative proportions of standardised medication units (SU)




Unweighted (%) Weighted by
mg ASA (%)
USA 58.2 48.3








Total 9 countries 100 100
100% = overall consumption of acetylic salicylic acid (ASA) among
nine countries
123
J Headache Pain (2008) 9:337
DOI 10.1007/s10194-008-0065-3
